Compare Amylx Pharmaceuticals Inc (AMLX) vs Palo Alto Networks Inc (PANW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Palo Alto Networks Inc — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Palo Alto Networks Inc trades at $381.9 (market cap $312.80B). The key difference: Palo Alto Networks Inc is far larger — about 118.5× Amylx Pharmaceuticals Inc's market cap. Which is the better fit depends on your goals.
| AMLX | PANW | |
|---|---|---|
Market Cap | $2.64B | $312.80B |
Sector | Health | Technology |
52-Week High | $24.19 | $385.04 |
52-Week Low | $7.82 | $141.67 |
Enterprise Value | $2.39B | $311.76B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Palo Alto Networks Inc
Palo Alto Networks is a pure-play cybersecurity vendor that sells security appliances, subscriptions, and support into enterprises, government entities, and service providers. The company's product portfolio includes firewall appliances, virtual firewalls, endpoint protection, cloud security, and cybersecurity analytics. The Santa Clara, California, firm was established in 2005 and sells its products worldwide.
Read more on PANW →
